About
Synthetic Peptides to Treat Cancer
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyAustralia
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
500
By Phase
PHASE2: 3
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
Today
Hover over trial bars to see details
Recent Trials
NCT02279823Lead Sponsor
A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
PHASE2Completed
95 participants
Started: Oct 31, 2014 · Completed: May 31, 2016
NCT01831960Lead Sponsor
An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris
PHASE2Completed
42 participants
Started: Apr 30, 2013 · Completed: Nov 30, 2013
NCT01631474Lead Sponsor
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
PHASE2Completed
363 participants
Started: Jun 30, 2012 · Completed: Feb 28, 2014
Locations (1)
Headquarters
Lane Cove West, Australia
Map
Loading map...